← Back
Data updated: Mar 29, 2026
OXFORD PHARMS
CardiovascularImmunologyNeurology
Generics
OXFORD PHARMS is a generic drug manufacturer focused on Cardiovascular, Immunology, Neurology.
1971
Since
30
Drugs
-
Trials
387
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
GLYCOPYRROLATE 2026-02-10
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
AMLODIPINE BESYLATE 2026-01-26
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 33%
3 drugs
Immunology 22%
2 drugs
Neurology 22%
2 drugs
Gastroenterology 11%
1 drugs
Metabolic 11%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Takeda big-pharma
Immunology, Gastroenterology, Neurology, Metabolic
Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic
Amgen biotech
Immunology, Metabolic, Gastroenterology, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Metabolic, Immunology
Active (14)
Discontinued (16)
AMLODIPINE BESYLATE GLYCOPYRROLATE TRAZODONE HYDROCHLORIDE LORAZEPAM CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TIZANIDINE HYDROCHLORIDE PAROXETINE HYDROCHLORIDE PRIMIDONE SPIRONOLACTONE ALPRAZOLAM METHOCARBAMOL CYCLOBENZAPRINE HYDROCHLORIDE CARISOPRODOL AND ASPIRIN CARISOPRODOL CAPTOPRIL DIPYRIDAMOLE
Company Info
- First Approval
- 1971-05-21
- Latest
- 2025-06-24
- Applications
- 33